National Cancer Institute; Notice of Meeting, 8727 [2014-03109]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 30 / Thursday, February 13, 2014 / Notices
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: February 7, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03111 Filed 2–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
emcdonald on DSK67QTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NINDS Clinical Trials SEP.
Date: January 9, 2014.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–435–6033, rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
VerDate Mar<15>2010
18:44 Feb 12, 2014
Jkt 232001
Dated: February 6, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03113 Filed 2–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
8727
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: February 7, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03109 Filed 2–12–14; 8:45 am]
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: February 21, 2014.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: NCI Update; Barriers to Drug
Development in Pediatric Cancer Research;
Advocate and Organizational Engagement.
Place: National Institutes of Health,
Building 31, C Wing, 6th Floor, Conference
Room 6, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Amy Bulman, Executive
Secretary, DCLG, Office of Advocacy
Relations, National Cancer Institute, 31
Center Drive, Building 31, Room 10A28,
Bethesda, MD 20892, 301–496–9723.
This notice is being submitted less than 15
days due to scheduling constraints.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2013–0065]
Agency Information Collection
Activities: Submission for Review;
Information Collection Request for the
Department of Homeland Security
(DHS), Science and Technology,
National Capital Region Secure
Delivery Technology Program
Science and Technology
Directorate, DHS.
ACTION: 60-day notice and request for
comment.
AGENCY:
The Department of Homeland
Security (DHS), Science & Technology
Directorate (S&T) invites the general
public to comment on data collection
forms for the National Capital Region
(NCR) Secure Delivery Technology
program. This is a new Paper Reduction
Act collection without an OMB control
number. Secure Delivery Technology is
responsible for improving the efficiency
and effectiveness of deliveries to
General Services Administration (GSA)
facilities in the NCR.
Information collected by Federal
Protective Service (FPS) personnel to
ensure secured deliveries in the NCR
includes the delivery driver’s name and
license number. The information
collected is used by FPS personnel to
verify the identity of the driver at the
delivery central screening facility and
final destination locations, along with
providing an auditable trail for postdelivery analysis should an event occur
that requires forensics.
DHS invites interested persons to
comment on the ‘‘National Capital
Region Secure Delivery Technology
Driver Log’’ form and instructions
(hereinafter ‘‘Forms Package’’) for the
S&T NCR Secure Delivery Technology.
Interested persons may receive a copy of
the Forms Package by contacting the
DHS S&T PRA Coordinator. This notice
and request for comments is required by
SUMMARY:
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 79, Number 30 (Thursday, February 13, 2014)]
[Notices]
[Page 8727]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03109]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer
Liaison Group.
Date: February 21, 2014.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: NCI Update; Barriers to Drug Development in Pediatric
Cancer Research; Advocate and Organizational Engagement.
Place: National Institutes of Health, Building 31, C Wing, 6th
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Amy Bulman, Executive Secretary, DCLG, Office of
Advocacy Relations, National Cancer Institute, 31 Center Drive,
Building 31, Room 10A28, Bethesda, MD 20892, 301-496-9723.
This notice is being submitted less than 15 days due to
scheduling constraints.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: February 7, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03109 Filed 2-12-14; 8:45 am]
BILLING CODE 4140-01-P
